WELIREG

Merck Canada Inc🇨🇦 Health Canada

Approval Id: aec72be5864740fd
Drug Approval Canada Name: WELIREG
Product Name: WELIREG
Status: Marketed
Status Date: 2022-09-01
Original Market Date: 2022-09-01
Din: 02528908
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 10:00.00
Atc Original: L01XX74 BELZUTIFAN
Atc Name: l 01 xx 74
Aig Number: 0163901001
Company Name: Merck Canada Inc
Company Address: 16750 Route Transcanadienne, Kirkland, Quebec, Canada, H9H 4M7

BELZUTIFAN

40 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

aec72be5864740fd

Type

Standard